Neumous
Latest round
- Series A
Last raised
- Jul 2025
Total raised
- $7M
Investors
- 5
About Neumous
Based in South Korea, Neumous Inc.Neumous Inc. specializes in creating advanced therapeutic ultrasound solutions aimed at facilitating drug delivery across the blood-brain barrier.Neumous is at the forefront of developing innovative therapeutic ultrasound medical devices, primarily focused on non-invasive solutions for opening the blood-brain barrier (BBB). Their core offering utilizes focused ultrasound technology to precisely target specific brain regions, allowing for the direct delivery of therapeutic agents intended to treat a variety of brain diseases, including brain tumors and Alzheimer's disease. This approach eliminates the need for traditional surgical interventions, providing significant advancements in personalized treatment. The company’s devices, officially released in January 2024 and December 2024, aim to serve healthcare providers, pharmaceutical companies, and research institutions across global markets, including North America, Europe, and Asia.Neumous generates revenue through strategic partnerships with pharmaceutical companies and healthcare institutions that utilize its ultrasound-BBB opening technology in clinical settings. The revenue model is based on B2B transactions, where healthcare providers and research entities purchase their ultrasound devices or the associated therapeutic services. The company’s flagship product, which enables BBB opening for drug delivery, is expected to be priced to reflect its innovative capabilities and clinical value. Partnerships may also involve collaborative research projects funded by governmental grants, enhancing the financial support for the development and deployment of their technologies.In July 2025, Neumous Inc. Future product launches are anticipated, particularly in expanding the application of their ultrasound technology in new therapeutic areas. Neumous is targeting expansion into markets across North America and Europe by 2026, aiming to solidify its presence in these regions with innovative medical solutions.
Who invested in Neumous
5 investors across 1 round
See all investors in Neumous
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 15, 2025
Amount
$7M
Investors
Questions about Neumous
Who invested in Neumous?
Neumous has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Neumous raised?
Neumous has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Neumous last raise money?
Neumous's most recent round on record is a Series A, in Jul 2025.
What does Neumous do?
Based in South Korea, Neumous Inc.
Where is Neumous headquartered?
Neumous is headquartered in Cheongju-si, South Korea.
Which VCs invest in companies like Neumous?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Neumous's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Neumous? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.